Novel Strategies for Discovery, Validation and FDA Approval of Biomarkers for Acute and Chronic Brain Injury

QR Code

Novel Strategies for Discovery, Validation and FDA Approval of Biomarkers for Acute and Chronic Brain Injury

None

Saved in:

Bibliographic Details
Main Authors:	Mondello, S., Kobeissy, F. H., Jeromin, A., Guingab-Cagmat, J. D., Zhiqun, Z., Streeter, J., Hayes, R. L., Wang, K. K.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/33549
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease
by: Israa J. Hakeem, et al.
Published: (2025-05-01)

THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS
by: article Editorial
Published: (2025-05-01)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023-11-01)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Published: (2025-07-01)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024-09-01)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023-12-01)

The FDA has approved a new drug for the treatment of leukemia
by: article editorial
Published: (2024-12-01)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE
by: article Editorial
Published: (2025-05-01)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024-09-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

Updated mini-review of the chemistry, pharmacology and validated assays for U.S. FDA approved COVID-19 therapeutic agents
by: Miranda F. Kamal, et al.
Published: (2022-06-01)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024-07-01)

THE FDA HAS APPROVED A NEW TREATMENT FOR HEMOPHILIA A OR B
by: Article Editorial
Published: (2024-11-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

FDA Has Approved First Long-Acting Growth Hormone Preparation for Children
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
by: article Editorial
Published: (2023-12-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023-05-01)

Biomarker Discovery, Validation and Clinical Application for Patients Diagnosed with Glioma
by: McDonald, Kerrie L.
Published: (2011)

Immunohistochemical Correlation of Novel Biomarkers with Neurodegeneration in Rat Models of Brain Injury
by: Gajavelli, Shyam, et al.
Published: (2012)

FDA HAS APPROVED NEW TREATMENT FOR CHILDREN WITH ANY HEPATITIS C VIRUS STRAINS
Published: (2020-04-01)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024-02-01)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023-08-01)

THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
by: Article Editorial
Published: (2024-11-01)

FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE FIRST DRUG FOR PEOPLE WITH PRADER – WILLI SYNDROME IN MEMORY OF A COLLEAGUE
by: article Editorial
Published: (2025-05-01)

Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T
by: Brill, Thomas H.
Published: (2011)

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)
by: Hassan Aliashrafzadeh, et al.
Published: (2025-07-01)